People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...
AL Amyloidosis is a rare and serious disease, with an estimated 8,600 incident cases in the 7MM countries (United States, EU5-Germany, France, Italy, Spain, and the United Kingdom-and Japan ...
The FDA has granted medical manufacturer Beckman Coulter a Breakthrough Device Designation for its new plasma ratio, a blood ...
Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.
REVEAL study for iodine 124I-evuzamitide (AT-01) in patients with suspected cardiac amyloidosis has begun enrollment by Brigham and ...
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- ...
Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta.
Innovative Research Combines Ayurvedic Medicine and Chemically Designed Peptides to Combat Amyloid Aggregation in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback